Merck to Acquire Prometheus Biosciences for $10.8B
Merck & Co. has agreed to acquire Prometheus Biosciences for about $10.8 billion, the companies said Sunday.
Source: genengnews.com
Stay updated with breaking news from Prometheus Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck & Co. has agreed to acquire Prometheus Biosciences for about $10.8 billion, the companies said Sunday.